Companion Diagnostics Market: Global Industry Analysis and Forecast to 2020

1 Companion Diagnostics Market: Global Industry Analysis and Forecast to 2020 Persistence Market Research Companion Diagnostics Market: Global Industry Analysis and Forecast to 2020 Persistence Market Research 1 2 Companion Diagnostics Market: Global Industry Analysis and Forecast to 2020 Persistence Market Research Released New Market Report on “Companion Diagnostics Market: Global Industry Analysis and Forecast to 2020” Companion diagnostics refer to the test or measurement which provides essential information about the patient’s genetic and genomic characteristics to the physicians for making treatment decision This information is important for the safe and effective use of corresponding drugs and therapies in the treatment Rise in awareness about personalized medicines, technological advancement and government initiatives are some of the major factors which are driving the companion diagnostics market Companion diagnostics helps to improve clinical outcome and cost saving Companion diagnostics are used in drug discovery and development in a cost effective manner In addition, companion diagnostics also used to manage side effects from the drug and therapies On the basis of technology, companion diagnostics market can be segmented into polymerase chain reaction (PCR), in-situ hybridization (ISH), immunohistochemistry (IHC) and others On the basis of application, companion diagnostics market can be segmented into breast cancer, gastric cancer, lung cancer, colorectal cancer, melanoma and others On the basis of end user, companion diagnostics market can be segmented into pharmaceutical companies, reference lab and others Companion diagnostics methodology includes genetic tests platforms, enzyme-linked immunosorbent assays, immunohistochemistry, proteomic assays and others Companion diagnostics reduce costs related to hospitalization due to unnecessary treatment Buy Full Report: http://wwwpersistencemarketresearchcom/market-research/companion- diagnostics-marketasp North America, followed by Europe, has the largest market for companion diagnostics due to FDA initiatives, increasing focus on personalized medicine, technological advancement and developed healthcare infrastructure in this region Asia is expected to experience high growth rate in the companion diagnostics market in next few years due to rise in incidence of cancer cases, government initiatives, increasing disposable income, developing healthcare infrastructure and rise in need for better oncology treatment in the region Government initiatives, growing need for targeted cancer treatment, increasing disposable income, technological advancement, development of personalized medicines and its adoption, rise in cost of drug discovery and increasing adoption of companion diagnostics by reference laboratories and pharmaceutical companies are expected to drive the market for companion diagnostics In addition, rise in incidence of life threatening diseases, growing awareness about personalized healthcare and increasing demand for better healthcare facilities are expected to drive the market for companion diagnostics However, reimbursement issues, non-validated laboratory developed tests, regulatory restrictions, huge Persistence Market Research 2 3 Companion Diagnostics Market: Global Industry Analysis and Forecast to 2020 time consuming approval process and high cost for procedure are some of the major factors restraining the growth for global companion diagnostics market Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in companion diagnostics market in Asia In addition, broader application area for companion diagnostics, growing bioinformatics field, rise in awareness about the companion diagnostics and forthcoming next generation sequencing based companion diagnostics are expected to offer new opportunities for global companion diagnostics market Increasing number of mergers and acquisitions, new product launches and rise in number of collaborations and partnerships are some of the latest trends that have been observed in global companion diagnostics market Some of the major companies operating in the global companion diagnostics market are Abbott Laboratories, Roche Holdings AG, GE Healthcare, Quagen NV, Genomic Health, Inc and Agilent Technologies, Inc In addition, some other companies operating in global companion diagnostics market are Thermo Fisher Scientific Inc, Myriad Genetics Inc, Biomérieux, Danaher Corporation and Biogenex Laboratories Request Full TOC: http://wwwpersistencemarketresearchcom/toc/3592 Key points covered in the report:- 1 Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2 The report covers geographic segmentation  North America  Europe  Asia  RoW 3 The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4 The report provides company profiles of some of the leading companies operating in the market 5 The report also provides porters five forces analysis of the market Browse the full “All Upcoming Persistence Market's ” report at http://wwwpersistencemarketresearchcom/forthcoming-reportsasp About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services Persistence Market Research 3 4 Companion Diagnostics Market: Global Industry Analysis and Forecast to 2020 At Persistence Market Research (PMR), we are in the business of accelerating your business As a full-service market research firm, we stand committed to bringing more accuracy and speed to your business decisions From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability PMR’s Services Go Beyond Gleaning Data: Most enterprises believe that IT and databases are enough to make an accurate decision While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines Facilitating Rapid and Informed Business Decisions PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by carefully balancing traditional and modern-day research methodologies Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States Phone: +1-646-568-7751 USA/Canada Toll Free Number 1-800-961-0353 E-mail: Salespersistencemarketresearchcom Web : http://wwwpersistencemarketresearchcom/ Persistence Market Research 4